Methotrexate in early rheumatoid arthritis: Is the anchor drug still holding?
Alessandro Giollo, Enrico Fuzzi, Andrea Doria
Topics & Concepts
MedicineMethotrexateRheumatoid arthritisTolerabilityAdverse effectDrugInternal medicineJanus kinaseDiseaseIntensive care medicineOncologyPharmacologyCytokineRheumatoid Arthritis Research and TherapiesChronic Lymphocytic Leukemia ResearchSystemic Lupus Erythematosus Research